跳至主要内容
临床试验/NCT05964088
NCT05964088已完成不适用

Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients

Arrowhead Regional Medical Center1 个研究点 分布在 1 个国家目标入组 267 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
267
试验地点
1
主要终点
Mortality

研究概览

简要总结

This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • positive for SARS-CoV-2 on a real-time polymerase chain reaction test (RT-PCR) upon admission to the hospital

排除标准

  • chronic kidney disease end stage renal disease

结局指标

主要结局

Mortality

时间窗: from admission until death from any cause, whichever comes first, assessed up to three months

mortality at hospital discharge

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Neeki

Attending Physician

Arrowhead Regional Medical Center

研究点 (1)

Loading locations...

相似试验